NK cells-derived extracellular vesicles potency in the B cell lymphoma biotherapy
This study underscore the importance of NKEV as a novel biological acellular tool for B-cell lymphoma treatment, probably having a greater effect on combined treatment regimens. These nanovesicles have an extraordinary potential in innovative cancer immunotherapy, representing a safe and efficient tool naturally circulating in healthy individuals and ready to maintain the immune homeostasis, and therefore a good organism healthy state.
Authors
- Mattea Chirico (ORCID: https://orcid.org/0000-0002-3447-5077)
- Cristina Federici (ORCID: https://orcid.org/0000-0001-6366-0231)
- Luana Lugini (ORCID: https://orcid.org/0000-0002-8778-2601)
- Serena Cecchetti (ORCID: https://orcid.org/0000-0002-3601-176X)
- Massimo Spada
- Marialuisa Casella (ORCID: https://orcid.org/0000-0003-0245-6709)
- Serena Camerini (ORCID: https://orcid.org/0000-0001-6131-4335)
- Rossella Canese (ORCID: https://orcid.org/0000-0001-9093-6803)
- Elisabetta Iessi (ORCID: https://orcid.org/0000-0001-7221-9173)
- Egidio Iorio (ORCID: https://orcid.org/0000-0001-6673-3838)
- Maria Elena Pisanu (ORCID: https://orcid.org/0000-0002-0029-3523)
- Veronica Huber (ORCID: https://orcid.org/0000-0001-6304-3575)
- Andrea Matteucci (ORCID: https://orcid.org/0000-0002-2986-9290)
- Daniele Macchia
Institutions
- Istituto Superiore di Sanità (IT)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-12-06
- DOI
- https://doi.org/10.3389/fimmu.2024.1503857
- Citations
- 3
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 0.70